The production capacity of ibuprofen is concerned, and many companies respond: production and operation are normal

　　Experts say rational purchases should not be blindly hoarding medicines

　　Our reporter Zhang Min Zhang Xiaoyu

　　Recently, many places across the country have adjusted the management policies for the online and offline purchase of "four types of drugs", namely cough, antipyretic, antiviral, and antibiotic drugs, and canceled the real-name registration process.

In this context, citizens snapped up ibuprofen, a common antipyretic and analgesic drug, which aroused concern.

　　On December 6, a staff member of a pharmacy in Chaoyang District, Beijing told a reporter from the Securities Daily, "Currently there is no ibuprofen in stock, and it is expected to replenish in the afternoon. Consumers do not need to register their personal information when purchasing." The staff of another pharmacy in Shunyi District, Beijing also told reporters that there are more consumers buying ibuprofen online now, and it takes two or three days to replenish ibuprofen.

　　The reporter searched the State Food and Drug Administration using ibuprofen as a keyword and found that there were a total of 558 approval numbers, involving hundreds of manufacturers, including China Resources Double Crane and CSPC.

The reporter also contacted companies with production approval documents by phone to inquire about production capacity and production status. Among them, the relevant person in charge of CSPC said: "The production and operation of ibuprofen is normal at present. The company's ibuprofen involves tablet and granule dosage forms, and the annual production capacity adds up to about 1 billion tablets (bags)."

　　On the investor interaction platform, the capacity and production of ibuprofen also attracted attention.

　　Xinhua Pharmaceutical stated on the investor interaction platform on December 5 that the company is an important global manufacturer of antipyretic and analgesic APIs, including ibuprofen, aspirin, metamizole, aminopyrine, antipyrine, isopropyl Antipyrine, tramadol, meloxicam and other varieties, the production capacity and scale of the main varieties are in a leading position, and the industrial chain has been realized, and the quality certification of the European and American standardized markets has been passed, and the market competitiveness is very obvious.

The actual market share of the company's ibuprofen is close to 40%.

　　On the same day, Hendy Pharmaceutical also stated on the investor interaction platform that the company's current production capacity of ibuprofen API is 3,500 tons per year, and its production and operation are normal.

　　Rundu shares stated on the investor interaction platform on November 23 that the company's product ibuprofen sustained-release capsules has passed the quality and efficacy consistency evaluation of generic drugs by the State Food and Drug Administration and won the bid for the third batch of national drug centralized procurement in 2020.

At present, this product is sold in all provinces of the country (except Hong Kong, Macao, and Taiwan), and the production capacity can meet the current sales demand.

The company will pay attention to market changes in a timely manner, make full use of existing production capacity, and maintain a good relationship between supply and demand.

　　Darentang also said in response to investors' questions recently that the production capacity of the ibuprofen suspension produced by the company's joint stock company Sino-American SmithKline is sufficient.

　　Regarding the growing demand for drugs such as ibuprofen, the person in charge of Ali Health also told reporters: "Recently, the search volume for epidemic-related drugs, antigen self-testing agents, and N95 masks has increased significantly. Ali Health Pharmacy and Tmall Health are linking merchant brands. , production enterprises, logistics supply chain, etc., increase the supply of health and epidemic prevention materials, and fully guarantee the needs of users."

　　As the demand for some cold medicines rises, many parties call for rational preparation of medicines.

　　According to the information released on December 5 by the WeChat account "Guangdong Drug Administration" of the Guangdong Provincial Drug Administration, after the adjustment and optimization of the epidemic prevention and control measures, there has been a phenomenon of citizens rushing to buy drugs and "stocking up" in Guangzhou recently.

In this regard, the Guangdong Food and Drug Administration disclosed that recently Guangdong wholesale companies distributed about 3.6 million units of cold medicines to 55,000 retail pharmacies in the province every day, exceeding the highest demand in recent days. The supply of cold medicines in the province is sufficient. There is no need to blindly stock up on medicines, and you need to follow the advice of professional physicians and pharmacists when taking medicines.

　　For consumers rushing to buy ibuprofen and other drugs, Pang Bo, chief physician of the International Medical Department of Guang'anmen Hospital, China Academy of Chinese Medical Sciences, told the "Securities Daily" reporter: "For young and middle-aged people without underlying diseases, some respiratory mild symptoms occur. Symptoms, if it does not affect rest and normal life, it is not recommended to choose to take medicine by yourself first, you can rest more, drink plenty of water and wait for self-healing, do not blindly follow the trend and hoard medicine."

　　"If the symptoms have seriously affected the patient's rest and sleep, you can take over-the-counter antipyretics such as ibuprofen or antipyretic and analgesics to relieve symptoms. You need to be very cautious when taking hot analgesic drugs, and it is recommended to consult a doctor first. In addition, people with abnormal liver and kidney function or gastrointestinal diseases should use them with caution." Pang Bo further said.

(Securities Daily)